SCHEMBL20525529

SCHEMBL20525529

COc1c(OCC2CCNCC2)ccc2c(Oc3ccc(NC(=O)C(=O)NCc4cc(F)cc(C(F)(F)F)c4)cc3F)ccnc12

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.45
FLT3 P36888 3/20 0.41
KDR P35968 8/20 0.39
AXL P30530 1/20 0.36
BRAF P15056 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20525799 0.97 MET (0.46) METFLT3KDRAXLBRAF
SCHEMBL20525693 0.94 MET (0.48) METFLT3KDRAXL
SCHEMBL20525659 0.93 MET (0.46) METFLT3KDRAXL
SCHEMBL20525802 0.92 MET (0.46) METFLT3KDRBRAF
SCHEMBL20525653 0.90 MET (0.48) METFLT3KDRAXL
SCHEMBL20525701 0.89 MET (0.49) METFLT3KDRAXL
SCHEMBL20525622 0.89 MET (0.45) METFLT3KDRAXLBRAF
SCHEMBL20525834 0.89 MET (0.45) METFLT3KDRAXL
SCHEMBL20525565 0.89 MET (0.47) METFLT3KDRAXL
SCHEMBL20525667 0.89 MET (0.53) METFLT3KDRAXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 EP claimed